Tanya Chandra

Rheumatologist at UPMC Mercy | UPMC Myositis & Georgetown Rheumatology Graduate | Opinions are my own

[Rohit Aggarwal @docrota]

I am forever grateful for amazing global mentees and colleagues in Myositis. Myositis research feels like fun because of all of you!

[Rohit Aggarwal @docrota]

Our Pittsburgh Myositis Center’s MAD (Myositis Accelerated Discovery) group at #ACR2024

[UPMC Mercy Internal Medicine Residency @UPMCMercyIM]

Congratulations to our exceptional PGY3 resident, Akanksha Sharma, on successfully matching into the Rheumatology Fellowship at the prestigious Mayo Clinic in Rochester! Wishing you continued success in this next exciting chapter of your journey.
#RheumTwitter #rheumatology

[Rohit Aggarwal @docrota]

Another excellent oral presentation from UPMC myositis center by Shiri Keret at #EULAR2024. She showed that many myositis patient may have normal CK despite muscle weakness. However, CK is associated with outcomes over time even in patients with normal or near normal CK, highlighting importance of follow up of CK even within normal range.

[Tanya Chandra @ChandraTanya]

@americanaib__ Hi now I’m on a 48 hour delay from my original itinerary and still stuck in ORD.
LEEBXB is my booking reference

[Tanya Chandra @ChandraTanya]

@AmericanAir Now there is at least a 48 hour delay from my original intended departure. Tell me who I need to talk to about this as this can not just be soemthing I’m supposed to accept

[Tanya Chandra @ChandraTanya]

@JisnaPaul @docrota @UPMC @PittRheum Thank you!

[Tanya Chandra @ChandraTanya]

@docrota Thank you for your support and guidance!

[Alexander Oldroyd @Dr_Alex_Oldroyd]

Thanks to ChatGPT for helping to resolve the debate!
💪💉🩸💬

[Alexander Oldroyd @Dr_Alex_Oldroyd]

Delighted that the #myositis cancer screening guideline has been published in @NatRevRheumatol
Recommendations address:
➡️Individualised cancer risk stratification
➡️Cancer screening modalities
➡️Cancer screening frequency

🔎Aims to facilitate early cancer detection

[NatRevRheumatol @NatRevRheumatol]

New content online! International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative https://t.co/cN32vS0cEm

[Rohit Aggarwal @docrota]

Proud of @UPMCPhysicianEd @PittTweet @PittDeptofMed @UPMC and @Boehringer for excellent collaboration to revolutionize the clinical studies for rare diseases like myositis and ILD @TheMyositisAssc @MyositisSupport @PFFORG @ActionPFcharity

[David Liew @drdavidliew]

Data from combined big Scandinavian population registries looking at both RA and PsA, ILD development, & MTX exposure

Here’s the ILD risk for methotrexate.

Can we stop this MTX misinformation? No more besmirching a really useful drug for our patients #EULAR2023 OP0006 @RheumNow

[Tanya Chandra @ChandraTanya]

@Janetbirdope Lupus

[Tanya Chandra @ChandraTanya]

Definitely need this @ACRheum

[Didem Saygin, MD @DidemSayginMD]

Well done @ASCO! Hope to see a similar support from @ACRheum to provide a common platform for IMGs in rheumatology to discuss and tackle the challenges that they experience. IMGs constitute 1/3 of the current rheumatology fellows and active rheumatology workforce in the US

[Tanya Chandra @ChandraTanya]

Check out our review of the use of Repository Corticotrophin Injection in myositis. This can be considered for use in refractory myositis patients if there is improved access
https://t.co/Dcspll2X3p @docrota

[Tanya Chandra @ChandraTanya]

@MoniqueDowdy6 @PittRheum @UPMC @PittDeptofMed Me too! Thank you :)

[PittRheum @PittRheum]

#Myositispearl's keep coming!
#Myositis

[Tanya Chandra @ChandraTanya]

@docrota @Georgetown @PittRheum So grateful to be given this opportunity. Thank you!